Back to Research

Organization profile

Centenara Labs

Centenara Labs is a longevity-focused biotechnology holding company that develops and invests in therapies targeting the biological hallmarks of aging to expand human healthspan. The organization builds a diversified portfolio of clinical and pre-clinical ventures addressing vision loss, cancer, fibrosis, and sarcopenia.11

Baar, SwitzerlandFounded 2013

Overview

1. Executive Summary (Confidence: High)

Centenara Labs, formerly known as Rejuveron Life Sciences AG, is a prominent player in the Swiss and global longevity biotechnology sector. Founded and chaired by entrepreneur Christian Angermayer, the firm operates as a venture-builder and strategic investor, focusing on the "Hallmarks of Aging". Centenara employs a platform-based model to de-risk the development of longevity drugs by spreading investment across multiple technologies and clinical indications. Its portfolio currently includes several clinical-stage assets, most notably through Endogena Therapeutics, which is developing regenerative treatments for ophthalmology. With a leadership team of experienced drug developers and a scientific advisory board featuring aging research luminaries, Centenara is strategically positioned to translate breakthrough discoveries into approved geriatric therapies.

Unlock the full profileGet the complete company dossier

This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.